Mounira Dchar-Chalabi
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Exploring and bypassing resistance to targeted therapies in colorectal cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 23, 2025
Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer.
Journal: Breast cancer research : BCR
Published: April 22, 2025
The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release.
The endoplasmic reticulum pool of Bcl-xL prevents cell death through IP3R-dependent calcium release.
Journal: Cell death discovery
Published: April 12, 2024
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
Journal: Cell death & disease
Published: September 12, 2022
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Journal: Cancers
Published: July 01, 2022
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation.
Journal: Cancers
Published: July 13, 2021
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.
Journal: Nature communications
Published: May 25, 2020
AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: January 22, 2019
Last Updated: 09/26/2026